Cases 1 - 9 of 9
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 2:2020cv13103
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Counter Claimant:
MYLAN LABORATORIES LIMITED
Defendant:
MYLAN PHARAMACEUTICALS, INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED
as 3:2021cv15137
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 3:2020cv13103
Plaintiff:
JANSSEN RESEARCH & DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV and JANSSEN PHARMACEUTICALS, INC.
Defendant:
MYLAN INSTITUTIONAL LLC, MYLAN LABORATORIES LIMITED and MYLAN PHARAMACEUTICALS, INC.
Cause Of Action: 15 U.S.C. § 1126
BTG INTERNATIONAL LIMITED et al v. MSN PHARMACEUTICALS INC. et al
as 2:2018cv02372
Plaintiff:
BTG INTERNATIONAL LIMITED , JANSSEN BIOTECH, INC. , JANSSEN ONCOLOGY, INC. and others
Defendant:
MSN PHARMACEUTICALS INC. and MSN LABORATORIES PRIVATE LIMITED
Cause Of Action: 15 U.S.C. § 1126
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA INC.
as 3:2017cv12082
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
AUROBINDO PHARMA USA INC.
Counter_claimant:
AUROBINDO PHARMA USA INC.
Counter_defendant:
CILAG GMBH INTERNATIONAL , JANSSEN PHARMACEUTICA NV , JANSSEN PHARMACEUTICALS, INC. and others
Cause Of Action: 15 U.S.C. § 1126
BTG INTERNATIONAL LIMITED et al v. TEVA PHARMACEUTICALS USA, INC.. et al
as 2:2017cv06435
Plaintiff:
BTG INTERNATIONAL LIMITED , JANSSEN BIOTECH, INC. , JANSSEN ONCOLOGY, INC. and others
Defendant:
TEVA PHARMACEUTICALS USA, INC.. and TEVA PHARMACEUTICALS INDUSTRIES LTD.
Cause Of Action: 35 U.S.C. § 145
BTG INTERNATIONAL LIMITED et al v. GLENMARK PHARMACEUTICALS INC., USA et al
as 2:2016cv03743
Plaintiff:
BTG INTERNATIONAL LIMITED , JANSSEN BIOTECH, INC. , JANSSEN ONCOLOGY, INC. and others
Defendant:
GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS SA and GLENMARK PHARMACEUTICALS LTD.
Cause Of Action: 15 U.S.C. § 1126
BTG INTERNATIONAL LIMITED et al v. AMERIGEN PHARMACEUTICALS, INC. et al
as 2:2016cv02449
Plaintiff:
BTG INTERNATIONAL LIMITED , JANSSEN BIOTECH, INC. , JANSSEN ONCOLOGY, INC. and others
Defendant:
AMERIGEN PHARMACEUTICALS, INC. and AMERIGEN PHARMACEUTICALS LTD.
Counter_claimant:
AMERIGEN PHARMACEUTICALS, INC. and AMERIGEN PHARMACEUTICALS LTD.
Counter_defendant:
BTG INTERNATIONAL LIMITED , JANSSEN BIOTECH, INC. , JANSSEN ONCOLOGY, INC. and others
Cause Of Action: 35 U.S.C. § 271
BTG INTERNATIONAL LIMITED et al v. ACTAVIS LABORATORIES FL, INC. et al
as 2:2015cv05909
Plaintiff:
BTG INTERNATIONAL LIMITED , JANSSEN BIOTECH, INC. , JANSSEN ONCOLOGY, INC. and others
Defendant:
ACTAVIS LABORATORIES FL, INC., ACTAVIS PHARMA, INC., ACTAVIS, INC. and others
Cause Of Action: 35 U.S.C. § 145
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
